Correlation Between 10X Genomics and NewCardio
Can any of the company-specific risk be diversified away by investing in both 10X Genomics and NewCardio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 10X Genomics and NewCardio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 10X Genomics and NewCardio, you can compare the effects of market volatilities on 10X Genomics and NewCardio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 10X Genomics with a short position of NewCardio. Check out your portfolio center. Please also check ongoing floating volatility patterns of 10X Genomics and NewCardio.
Diversification Opportunities for 10X Genomics and NewCardio
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between 10X and NewCardio is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding 10X Genomics and NewCardio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NewCardio and 10X Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 10X Genomics are associated (or correlated) with NewCardio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NewCardio has no effect on the direction of 10X Genomics i.e., 10X Genomics and NewCardio go up and down completely randomly.
Pair Corralation between 10X Genomics and NewCardio
If you would invest 0.00 in NewCardio on December 2, 2024 and sell it today you would earn a total of 0.00 from holding NewCardio or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 98.36% |
Values | Daily Returns |
10X Genomics vs. NewCardio
Performance |
Timeline |
10X Genomics |
NewCardio |
10X Genomics and NewCardio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with 10X Genomics and NewCardio
The main advantage of trading using opposite 10X Genomics and NewCardio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 10X Genomics position performs unexpectedly, NewCardio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NewCardio will offset losses from the drop in NewCardio's long position.10X Genomics vs. Twist Bioscience Corp | 10X Genomics vs. Fate Therapeutics | 10X Genomics vs. Beam Therapeutics | 10X Genomics vs. Veracyte |
NewCardio vs. CVRx Inc | NewCardio vs. Bone Biologics Corp | NewCardio vs. Delcath Systems | NewCardio vs. Heart Test Laboratories |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |